Platino-resistance in Ovarian Cancer

Prospective, monocentric study aiming to identify factors involved in platinum based-chemotherapy resistance in patients with epithelial ovarian cancer (all stages). Patients will receive treatment (platinum based-chemotherapy) according to the standard practices. A prospective database and an associated biological collection will be performed during 5 years: * For each patient: clinical, biological, epidemiological and therapeutic treatment data will be collected during the standard therapeutic care. * Biological samples (blood samples, tumor biopsy specimens and ascites samples) will be c

Trial Details

NCT ID
NCT03954171
Phase
NA
Sponsor
Institut Claudius Regaud
Status
RECRUITING
Cancer Type
Ovarian Cancer
Interventions
  • Patients treated with platinum based-chemotherapy
Locations (sample)
  • Toulouse, France|43.60426,1.44367

Key Eligibility Criteria

  • Age ≥ 18 years old
  • Epithelial ovarian cancer at initial diagnosis (all stages)
  • Curative treatment (exeresis surgery) not yet initiated excepted neo-adjuvant treatment
  • Indication of platinum based-chemotherapy

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Ovarian Cancer Trials on Trialify →